| Notice to Amend Foreign Institution Eligibility in PAR-12-206 Decreasing Patient Radiation Dose from CT Imaging: Achieving Sub-mSv Studies (U01) |
NOT-EB-13-003 |
|
|
Notice to Amend PAR-12-206 to Allow Inclusion of Foreign Sub-Components or Sub-Contractors of U.S. Organizations
|
NOT-EB-12-004 |
|
|
| Notice to Clarify NIBIB's Research Objectives Under PAR-19-134, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)" |
NOT-EB-19-002 |
|
|
| Notice to Clarify the Types of Clinical Trials NIBIB Will Support Under PA-18-048 Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional) |
NOT-EB-18-007 |
|
|
| Notice to Clarify the Types of Clinical Trials NIBIB Will Support Under PAR-18-206 Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) |
NOT-EB-18-002 |
|
|
| Notice to Clarify the Types of Clinical Trials NIBIB Will Supported Under PAR-18-208 Bioengineering Research Partnerships (U01 Clinical Trial Optional) |
NOT-EB-18-004 |
|
|
| Notice to Encourage Eligible NIH BRAIN Initiative Awardees to Apply for Administrative Supplements to Promote Diversity, PA-16-288 " Research Supplements to Promote Diversity in Health -Related Research (Admin Supp)" |
NOT-MH-17-008 |
|
|
| Notice to Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-16-288 "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)" |
NOT-MH-17-048 |
|
|
| Notice to Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-18-906 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
NOT-DA-18-038 |
|
|
| Notice To Extend PA-10-009 Bioengineering Research Grants (BRG) (R01) |
NOT-EB-13-001 |
|
|
